- Home
- TVGN vs CHMG Comparison
TVGN vs CHMG Comparison
Compare TVGN & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- CHMG
- Stock Information
- Founded
- TVGN 2020
- CHMG 1833
- Country
- TVGN United States
- CHMG United States
- Employees
- TVGN N/A
- CHMG N/A
- Industry
- TVGN Blank Checks
- CHMG Major Banks
- Sector
- TVGN Finance
- CHMG Finance
- Exchange
- TVGN Nasdaq
- CHMG Nasdaq
- Market Cap
- TVGN 193.1M
- CHMG 225.3M
- IPO Year
- TVGN N/A
- CHMG N/A
- Fundamental
- Price
- TVGN $1.20
- CHMG $46.90
- Analyst Decision
- TVGN Strong Buy
- CHMG Hold
- Analyst Count
- TVGN 1
- CHMG 3
- Target Price
- TVGN $10.00
- CHMG $55.00
- AVG Volume (30 Days)
- TVGN 817.5K
- CHMG 10.8K
- Earning Date
- TVGN 08-13-2025
- CHMG 07-17-2025
- Dividend Yield
- TVGN N/A
- CHMG 2.74%
- EPS Growth
- TVGN N/A
- CHMG N/A
- EPS
- TVGN N/A
- CHMG 4.74
- Revenue
- TVGN N/A
- CHMG $96,163,000.00
- Revenue This Year
- TVGN N/A
- CHMG $11.98
- Revenue Next Year
- TVGN N/A
- CHMG $8.47
- P/E Ratio
- TVGN N/A
- CHMG $9.86
- Revenue Growth
- TVGN N/A
- CHMG 0.44
- 52 Week Low
- TVGN $0.26
- CHMG $40.71
- 52 Week High
- TVGN $3.09
- CHMG $55.73
- Technical
- Relative Strength Index (RSI)
- TVGN 48.04
- CHMG 52.24
- Support Level
- TVGN $1.09
- CHMG $46.23
- Resistance Level
- TVGN $1.31
- CHMG $50.00
- Average True Range (ATR)
- TVGN 0.10
- CHMG 1.15
- MACD
- TVGN -0.02
- CHMG -0.07
- Stochastic Oscillator
- TVGN 26.19
- CHMG 39.10
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.